Methyl Prednisolonate
Subdeltoid Bursitis
Benha UniversityEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Subdeltoid Bursitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Xeomin® Benha University | Early Phase 1 | C |
HYALURONATE Shin Kong Wu Ho-Su Memorial Hospital | N/A | D |
LIDOCAINE Shin Kong Wu Ho-Su Memorial Hospital | N/A | D |
Same molecule, other indications
Methyl Prednisolonate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →